Clinical trial
Monitoring Natural Killer Cells in Multiple Sclerosis Patients Treated With Fingolimod
NCT01790269
Study timeline
Study start (unknown)2013-09-01Date precision: month
Registry last updated2021-07-29
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Relapsing-Remitting Multiple Sclerosisunresolved
Interventions
Sponsors & collaborators
Charite University, Berlin, Germanylead sponsor
Dr. Carmen Infante-Duartecollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01790269 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.